These data reveal a novel, previously unidentified role for ClfB-loricrin binding in the pathogenesis of S. aureus SSTI; thus, targeting this pathway may represent a novel approach for the prevention of S. aureus SSTI. The gene discussed is LORICRIN; the disease is skin and soft tissue Staphylococcus aureus infection.